17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: Protein structures, functions, and recent progress in inhibitor development

Jalview Version 2—a multiple sequence alignment editor and analysis workbench

Waterhouse, A. M., Procter, J. B., Martin, D. M. A., Clamp, M. E., & Barton, G. J. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp033 · Cited by 10,349

MAFFT version 5: improvement in accuracy of multiple sequence alignment

Katoh, K., Kuma, K., Toh, H., & Miyata, T. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki198 · Cited by 5,063

A transmembrane intracellular estrogen receptor mediates rapid cell signaling

Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., & Prossnitz, E. R. (2005) · Science · doi:10.1126/science.1106943 · Cited by 2,302

ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease

Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., et al. (2004) · Science · doi:10.1126/science.1091230 · Cited by 1,303

Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer

Stanbrough, M., Bubley, G. J., Ross, K., Golub, T. R., Rubin, M. A., Penning, T. M., Febbo, P. G., & Balk, S. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4000 · Cited by 1,082

Medium- and short-chain dehydrogenase/reductase gene and protein families: The SDR superfamily: functional and structural diversity within a family of metabolic and regulatory enzymes

Kavanagh, K. L., Jörnvall, H., Persson, B., & Oppermann, U. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8588-y · Cited by 908

Intracrinology

Labrie, F. (1991) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(91)90116-a · Cited by 685

Critical Residues for Structure and Catalysis in Short-chain Dehydrogenases/Reductases

Filling, C., Berndt, K. D., Benach, J., Knapp, S., Prozorovski, T., Nordling, E., Ladenstein, R., Jörnvall, H., & Oppermann, U. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202160200 · Cited by 583

The Effect of Postmenopausal Estrogen Therapy on Bone Density in Elderly Women

Felson, D. T., Zhang, Y., Hannan, M. T., Kiel, D. P., Wilson, P. W. F., & Anderson, J. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310143291601 · Cited by 580

Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3

Geissler, W. M., Davis, D. L., Wu, L., Bradshaw, K. D., Patel, S., Mendonca, B. B., Elliston, K. O., Wilson, J. D., Russell, D. W., & Andersson, S. (1994) · Nature Genetics · doi:10.1038/ng0594-34 · Cited by 570

Hormonal Therapy for Prostate Cancer

Desai, K. B., McManus, J. M., & Sharifi, N. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab002 · Cited by 475

Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review

Schiffer, L., Barnard, L., Baranowski, E. S., Gilligan, L. C., Taylor, A. E., Arlt, W., Shackleton, C. H. L., & Storbeck, K.-H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105439 · Cited by 450

17‐Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease

Ma, Y., Belyaeva, O. V., Brown, P. M., Fujita, K., Valles, K., Karki, S., de Boer, Y. S., Koh, C., Chen, Y., Du, X., et al. (2018) · Hepatology · doi:10.1002/hep.30350 · Cited by 317

The Role of Sex and Sex Hormones in Neurodegenerative Diseases

Vegeto, E., Villa, A. M., Torre, S. D., Crippa, V., Rusmini, P., Cristofani, R., Galbiati, M., Maggi, A. C., & Poletti, A. (2019) · Endocrine Reviews · doi:10.1210/endrev/bnz005 · Cited by 240

Comparative proteomic study reveals 17β-HSD13 as a pathogenic protein in nonalcoholic fatty liver disease

Su, W., Wang, Y., Jia, X., Wu, W., Li, L., Tian, X., Li, S., Wang, C., Xu, H.-M., Cao, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410741111 · Cited by 222

Current status on development of steroids as anticancer agents

Gupta, A. K., Kumar, B. S., & Negi, A. S. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.05.011 · Cited by 218

Intracrine androgen biosynthesis, metabolism and action revisited

Schiffer, L., Arlt, W., & Storbeck, K.-H. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.016 · Cited by 217

Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid Dehydrogenases

Kaserer, T., Beck, K. R., Akram, M., Odermatt, A., & Schuster, D. (2015) · Molecules · doi:10.3390/molecules201219880 · Cited by 214

Endometrial and endometriotic concentrations of estrone and estradiol are determined by local metabolism rather than circulating levels

Huhtinen, K., Desai, R., Ståhle, M., Salminen, A., Handelsman, D. J., Perheentupa, A., & Poutanen, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1154 · Cited by 195

The structural biology of oestrogen metabolism

THOMAS, M. P., & Potter, B. V. L. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2012.12.014 · Cited by 181

Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): Overview and structural insights

Byrns, M. C., Jin, Y., & Penning, T. M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.11.004 · Cited by 145

Splice variant rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver disease

Pirola, C. J., Garaycoechea, M. E., Flichman, D., Arrese, M. A., Martino, J. S., Gazzi, C., Castaño, G. O., & Sookoian, S. C. (2018) · Journal of Lipid Research · doi:10.1194/jlr.p089953 · Cited by 142

Estrogen metabolism in abdominal subcutaneous and visceral adipose tissue in postmenopausal women

Hetemäki, N., Savolainen-Peltonen, H., Tikkanen, M. J., Wang, F., Paatela, H., Hämäläinen, E., Turpeinen, U., Haanpää, M., Vihma, V., & Mikkola, T. S. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01474 · Cited by 140

AKR1C3 (type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase): Roles in malignancy and endocrine disorders

Penning, T. M. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.07.002 · Cited by 117

Estrogen biosynthesis and signaling in endometriosis

Huhtinen, K., Ståhle, M., Perheentupa, A., & Poutanen, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.08.022 · Cited by 107

Overexpression of Aromatase Alone is Sufficient for Ovarian Development in Genetically Male Chicken Embryos

Lambeth, L. S., Cummins, D. M., Doran, T. J., Sinclair, A. H., & Smith, C. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068362 · Cited by 82

Roles of 17β-hydroxysteroid dehydrogenase type 10 in neurodegenerative disorders

Yang, S., He, X., Isaacs, C. E., Dobkin, C., Miller, D. L., & Philipp, M. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.07.001 · Cited by 85

Current knowledge of the multifunctional 17β-hydroxysteroid dehydrogenase type 1 (HSD17B1)

He, W., Misra, G., Li, T., Wang, R., & Lin, S. (2016) · Gene · doi:10.1016/j.gene.2016.04.031 · Cited by 78

Multigenerational and Transgenerational Effects of Environmentally Relevant Concentrations of Endocrine Disruptors in an Estuarine Fish Model

DeCourten, B. M., Forbes, J. P., Roark, H. K., Burns, N. P., Major, K. M., White, J. W., Li, J., Mehinto, A. C., Connon, R. E., & Brander, S. M. (2020) · Environmental Science & Technology · doi:10.1021/acs.est.0c02892 · Cited by 76

The Sulfatase Pathway for Estrogen Formation: Targets for the Treatment and Diagnosis of Hormone-Associated Tumors

Secky, L., Svoboda, M., Klameth, L., Bajna, E., Hamilton, G., Zeillinger, R., Jäger, W. R., & Thalhammer, T. (2013) · Journal of Drug Delivery · doi:10.1155/2013/957605 · Cited by 71

Role of HSD17B13 in the liver physiology and pathophysiology

Su, W., Mao, Z., Liu, Y., Zhang, X., Zhang, W., Gustafsson, J.-Α., & Guan, Y. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.10.014 · Cited by 69

Activity of Zearalenone in the Porcine Intestinal Tract

Gajęcka, M., Zielonka, Ł., & Gajęcki, M. T. (2016) · Molecules · doi:10.3390/molecules22010018 · Cited by 66

17‐Beta Hydroxysteroid Dehydrogenase 13 Deficiency Does Not Protect Mice From Obesogenic Diet Injury

Ma, Y., Brown, P. M., Lin, D. D., Ma, J., Feng, D., Belyaeva, O. V., Podszun, M. C., Roszik, J., Allen, J. N., Umarova, R., et al. (2020) · Hepatology · doi:10.1002/hep.31517 · Cited by 64

Characteristics and sex dimorphism of 17β-hydroxysteroid dehydrogenase family genes in the olive flounder Paralichthys olivaceus

Zou, C., Wang, L., Zou, Y., Wu, Z., Wang, W., Liang, S., Wang, L., & You, F. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105597 · Cited by 61

In silico methods in the discovery of endocrine disrupting chemicals

Vuorinen, A., Odermatt, A., & Schuster, D. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.04.009 · Cited by 58

Engineering Mycobacterium smegmatis for testosterone production

Fernández‐Cabezón, L., Galán, B., & García, J. L. (2016) · Microbial Biotechnology · doi:10.1111/1751-7915.12433 · Cited by 58

Impact of estradiol structural modifications (18-methyl and/or 17-hydroxy inversion of configuration) on the in vitro and in vivo estrogenic activity

Ayan, D. P., Roy, J., Maltais, R., & Poirier, D. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.07.009 · Cited by 58

The Adrenal Cortex and its Disorders

Miller, W. L. (2009) · Wiley eBooks · doi:10.1002/9781444316728.ch13 · Cited by 51

Human hydroxysteroid dehydrogenases and pre-receptor regulation: Insights into inhibitor design and evaluation

Penning, T. M. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.01.009 · Cited by 50

Optimization of Hydroxybenzothiazoles as Novel Potent and Selective Inhibitors of 17β-HSD1

Spadaro, A., Frotscher, M., & Hartmann, R. W. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201711b · Cited by 50

Discovery of a novel enzyme mediating glucocorticoid catabolism in fish: 20beta-hydroxysteroid dehydrogenase type 2

Tokarz, J., Mindnich, R., Norton, W., Möller, G., Hrabé de Angelis, M., & Adamski, J. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.10.022 · Cited by 48

Emerging hallmarks of endometriosis metabolism: A promising target for the treatment of endometriosis

Lu, J., Ling, X., Liu, L., Jiang, A., Ren, C., Lü, C., & Yu, Z. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119381 · Cited by 48

Functional Silencing of HSD17B2 in Prostate Cancer Promotes Disease Progression

Gao, X., Dai, C. S., Huang, S., Tang, J., Chen, G., Li, J., Zhu, Z., Zhu, X., Zhou, S., Gao, Y., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2392 · Cited by 48

17β-Estradiol and Estradiol Fatty Acyl Esters and Estrogen-Converting Enzyme Expression in Adipose Tissue in Obese Men and Women

Wang, F., Vihma, V., Soronen, J., Turpeinen, U., Hämäläinen, E. K., Savolainen-Peltonen, H. M., Mikkola, T. S., Naukkarinen, J., Pietiläinen, K. H., Jauhiainen, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2605 · Cited by 48

Introduction of an Electron Withdrawing Group on the Hydroxyphenylnaphthol Scaffold Improves the Potency of 17β-Hydroxysteroid Dehydrogenase Type 2 (17β-HSD2) Inhibitors

Wetzel, M., Marchais‐Oberwinkler, S., Perspicace, E., Möller, G., Adamski, J., & Hartmann, R. W. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2008453 · Cited by 47

Friend or enemy? Review of 17β‐HSD10 and its role in human health or disease

Vinklářová, L., Schmidt, M., Benek, O., Kuča, K., Gunn‐Moore, F. J., & Musílek, K. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15027 · Cited by 43

Breast Adipose Tissue Estrogen Metabolism in Postmenopausal Women With or Without Breast Cancer

Savolainen-Peltonen, H. M., Vihma, V., Leidenius, M., Wang, F., Turpeinen, U., Hämäläinen, E. K., Tikkanen, M. J., & Mikkola, T. S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2550 · Cited by 41

Danggui-Shaoyao-San Improves Gut Microbia Dysbiosis and Hepatic Lipid Homeostasis in Fructose-Fed Rats

Yin, J., Lu, J., Peng, L., He, M., Huang, S., Lv, J., Zhu, Y., Liu, Z., & Jiang, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.671708 · Cited by 39

Direct and indirect parental exposure to endocrine disruptors and elevated temperature influences gene expression across generations in a euryhaline model fish

DeCourten, B. M., Connon, R. E., & Brander, S. M. (2019) · PeerJ · doi:10.7717/peerj.6156 · Cited by 39

Virtual screening applications in short-chain dehydrogenase/reductase research

Beck, K. R., Kaserer, T., Schuster, D., & Odermatt, A. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.03.008 · Cited by 38

Inhibitors of 17β-hydroxysteroid dehydrogenase type 1, 2 and 14: Structures, biological activities and future challenges

Salah, M., Abdelsamie, A. S., & Frotscher, M. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.10.001 · Cited by 38

Hydroxybenzothiazoles as New Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1)

Spadaro, A., Negri, M., Marchais‐Oberwinkler, S., Bey, E., & Frotscher, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029252 · Cited by 36

Omic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease

Zhang, X., Wang, Y., & Liu, P. (2016) · Protein & Cell · doi:10.1007/s13238-016-0327-9 · Cited by 36

Enzymatic preparation of Crassostrea oyster peptides and their promoting effect on male hormone production

Zhang, W., Wei, Y., Cao, X., Guo, K., Wang, Q., Xiao, X., Zhai, X., Wang, D., & Huang, Z. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113382 · Cited by 35

Hydroxysteroid (17β) dehydrogenase 12 is essential for metabolic homeostasis in adult mice

Heikelä, H., Ruohonen, S. T., Adam, M., Viitanen, R., Liljenbäck, H., Eskola, O., Gabriel, M., Mairinoja, L., Pessia, A., Velagapudi, V., et al. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00042.2020 · Cited by 34

Synthesis and structure–activity relationships of 2- and/or 4-halogenated 13β- and 13α-estrone derivatives as enzyme inhibitors of estrogen biosynthesis

Bacsa, I., Herman, B. E., Jójárt, R., Herman, K. S., Woelfling, J., Schneider, G., Varga, M., Tömböly, C., Rižner, T. L., Szécsi, M., et al. (2018) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1490731 · Cited by 33

Discovery of a Non-Estrogenic Irreversible Inhibitor of 17β-Hydroxysteroid Dehydrogenase Type 1 from 3-Substituted-16β-( m -carbamoylbenzyl)-estradiol Derivatives

Maltais, R., Ayan, D. P., Trottier, A., Barbeau, X., Lagüe, P., Bouchard, J., & Poirier, D. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401639v · Cited by 33

Diagnostic and prognostic values of AKR1C3 and AKR1D1 in hepatocellular carcinoma

Zhu, P., Feng, R., Lu, X., Liao, Y., Du, Z., Zhai, W., & Chen, K. (2021) · Aging · doi:10.18632/aging.202380 · Cited by 32

The Effect of Low Monotonic Doses of Zearalenone on Selected Reproductive Tissues in Pre-Pubertal Female Dogs—A Review

Gajęcka, M., Zielonka, Ł., & Gajęcki, M. T. (2015) · Molecules · doi:10.3390/molecules201119726 · Cited by 32

Growth performance, selected blood biochemical parameters and body weights of pre-pubertal gilts fed diets supplemented with different doses of zearalenone (ZEN)

Rykaczewska, A., Gajęcka, M., Dąbrowski, M., Wiśniewska, A., Szcześniewska, J., Gajęcki, M. T., & Zielonka, Ł. (2018) · Toxicon · doi:10.1016/j.toxicon.2018.07.013 · Cited by 30

Characterization of essential domains in HSD17B13 for cellular localization and enzymatic activity

Ma, Y., Karki, S., Brown, P. M., Lin, D. D., Podszun, M. C., Zhou, W., Belyaeva, O. V., Kedishvili, N. Y., & Rotman, Y. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120000907 · Cited by 30

Structural basis of lipid-droplet localization of 17-beta-hydroxysteroid dehydrogenase 13

(2023) · doi:10.1038/s41467-023-40766-0 · Cited by 29

Characteristics of 17β-hydroxysteroid dehydrogenase 8 and its potential role in gonad of Zhikong scallop Chlamys farreri

Liu, J., Zhang, Z., Ma, X., Liang, S., & Yang, D. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.01.008 · Cited by 29

Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients

Benedittis, C. D., Bellan, M., Crevola, M., Boin, E., Barbaglia, M. N., Mallela, V. R., Ravanini, P., Ceriani, E., Fangazio, S., Sainaghi, P. P., et al. (2020) · Gastroenterology Research and Practice · doi:10.1155/2020/4216451 · Cited by 29

Molecular cloning and expression analysis of 17β-hydroxysteroid dehydrogenase 1 and 12 during gonadal development, recrudescence and after in vivo hCG induction in catfish, Clarias batrachus

Anbazhagan, R., & Senthilkumaran, B. (2014) · Steroids · doi:10.1016/j.steroids.2014.09.009 · Cited by 29

Human DHRS7, promising enzyme in metabolism of steroids and retinoids?

Navrátilová, H., Zemanová, L., Lundová, T., Malčeková, B., Skarka, A., Šafr, M., & Wsól, V. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.09.041 · Cited by 28

Gonad transcriptome analysis reveals the differences in gene expression related to sex-biased and reproduction of clam Cyclina sinensis

Liu, M., Ni, H., Rong, Z., Wang, Z., Yan, S., Liao, X., & Dong, Z. (2023) · Frontiers in Marine Science · doi:10.3389/fmars.2022.1110587 · Cited by 27

Disrupting KATP channels diminishes the estrogen-mediated protection in female mutant mice during ischemia-reperfusion

Gao, J., Xu, D. H., Sabat, G., Valdivia, H. H., Xu, W. G., & Shi, N. (2014) · Clinical Proteomics · doi:10.1186/1559-0275-11-19 · Cited by 27

Structural basis for inhibition of 17β-hydroxysteroid dehydrogenases by phytoestrogens: The case of fungal 17β-HSDcl

Cassetta, A., Stojan, J., Krastanova, I. B., Kristan, K., Brunskole, M., Lamba, D., & Rižner, T. L. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.02.020 · Cited by 27

Discovery of a new class of bicyclic substituted hydroxyphenylmethanones as 17β-hydroxysteroid dehydrogenase type 2 (17β-HSD2) inhibitors for the treatment of osteoporosis

Wetzel, M., Gargano, E. M., Hinsberger, S., Marchais‐Oberwinkler, S., & Hartmann, R. W. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.09.004 · Cited by 25

Male-Dominant Activation of Rat Renal Organic Anion Transporter 1 (Oat1) and 3 (Oat3) Expression by Transcription Factor BCL6

Wegner, W., Burckhardt, B. C., Burckhardt, G., & Henjakovic, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035556 · Cited by 25

Combined Biophysical Chemistry Reveals a New Covalent Inhibitor with a Low-Reactivity Alkyl Halide

Li, T., Maltais, R., Poirier, D., & Lin, S. (2018) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.8b02225 · Cited by 25

Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open Science

Thamm, S., Willwacher, M. K., Aspnes, G. E., Bretschneider, T., Brown, N. F., Buschbom-Helmke, S., Fox, T., Gargano, E. M., Grabowski, D., Hoenke, C., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01884 · Cited by 24

Towards precision medicine in non-alcoholic fatty liver disease

Francque, S. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09820-6 · Cited by 25

Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark

Collin, L. J., Cronin-Fenton, D. P., Ahern, T. P., Christiansen, P., Damkier, P., Ejlertsen, B., Hamilton-Dutoit, S. J., Kjærsgaard, A., Silliman, R. A., Sørensen, H. T., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-021805 · Cited by 23

17β-hydroxysteroid dehydrogenases in the progression of nonalcoholic fatty liver disease

Wang, M., & Peng, Z. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108428 · Cited by 23

Crucial Role of 3-Bromoethyl in Removing the Estrogenic Activity of 17β-HSD1 Inhibitor 16β-(m-Carbamoylbenzyl)estradiol

Maltais, R., Ayan, D. P., & Poirier, D. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200093v · Cited by 23

The effect of experimental low zearalenone intoxication on ovarian follicles in pre-pubertal bitches

Gajęcka, M. (2013) · Polish Journal of Veterinary Sciences · doi:10.2478/pjvs-2013-0007 · Cited by 23

First Structure–Activity Relationship of 17β-Hydroxysteroid Dehydrogenase Type 14 Nonsteroidal Inhibitors and Crystal Structures in Complex with the Enzyme

Braun, F., Bertoletti, N., Möller, G., Adamski, J., Steinmetzer, T., Salah, M., Abdelsamie, A. S., van Koppen, C. J., Heine, A., Klebe, G., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01436 · Cited by 22

Determination of the topology of endoplasmic reticulum membrane proteins using redox-sensitive green-fluorescence protein fusions

Tsachaki, M., Birk, J., Egert, A., & Odermatt, A. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.04.002 · Cited by 22

Synthesis and Biological Evaluation of Triazolyl 13α-Estrone–Nucleoside Bioconjugates

Bodnár, B., Mernyák, E., Woelfling, J., Schneider, G., Herman, B. E., Szécsi, M., Sinka, I., Zupkó, I., Kupihár, Z., & Kovács, L. (2016) · Molecules · doi:10.3390/molecules21091212 · Cited by 22

Synthesis of novel 13α-estrone derivatives by Sonogashira coupling as potential 17β-HSD1 inhibitors

Bacsa, I., Jójárt, R., Woelfling, J., Schneider, G., Herman, B. E., Szécsi, M., & Mernyák, E. (2017) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.13.126 · Cited by 22

Intracrinology-revisited and prostate cancer

Penning, T. M., & Detlefsen, A. J. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105499 · Cited by 22

Molecular Mechanism Study on Stereo-Selectivity of α or β Hydroxysteroid Dehydrogenases

Gao, M., Nie, K., Qin, M., Xu, H.-J., Wang, F., & Liu, L. (2021) · Crystals · doi:10.3390/cryst11030224 · Cited by 22

The Genus Eriosema (Fabaceae): From the Ethnopharmacology to an Evidence-Based Phytotherapeutic Perspective?

Ateba, S. B., Njamen, D., & Krenn, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.641225 · Cited by 20

Psoralen prevents the inactivation of estradiol and treats osteoporosis via covalently targeting HSD17B2

Lu, Y., Zhang, M., Zhang, J., Jiang, M., & Bai, G. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116426 · Cited by 20

Identification of steroidal derivatives inhibiting the transformations of allopregnanolone and estradiol by 17β-hydroxysteroid dehydrogenase type 10

Boutin, S., Roy, J., Maltais, R., Alata, W., Calon, F., & Poirier, D. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.09.031 · Cited by 20

Rational design of 17β-hydroxysteroid dehydrogenase type3 for improving testosterone production with an engineered Pichia pastoris

Ding, J., You, S., Zhang, J., Zhang, H., Wang, H., Zhang, W., Qi, W. D., Su, R., & He, Z. (2021) · Bioresource Technology · doi:10.1016/j.biortech.2021.125833 · Cited by 20

Steroid sulfatase activity in subcutaneous and visceral adipose tissue: a comparison between pre- and postmenopausal women

Paatela, H., Wang, F., Vihma, V., Savolainen-Peltonen, H., Mikkola, T. S., Turpeinen, U., Hämäläinen, E., Jauhiainen, M., & Tikkanen, M. J. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0831 · Cited by 19

Pd-Catalyzed microwave-assisted synthesis of phosphonated 13α-estrones as potential OATP2B1, 17β-HSD1 and/or STS inhibitors

Jójárt, R., Pécsy, S., Keglevich, G., Szécsi, M., Laczkó-Rigó, R., Özvegy‐Laczka, C., Kecskeméti, G., & Mernyák, E. (2018) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.14.262 · Cited by 19

Synthesis of 17β-hydroxysteroid dehydrogenase type 10 steroidal inhibitors: Selectivity, metabolic stability and enhanced potency

Boutin, S., Maltais, R., Roy, J., & Poirier, D. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112909 · Cited by 19

A Targeted-Covalent Inhibitor of 17β-HSD1 Blocks Two Estrogen-Biosynthesis Pathways: In Vitro (Metabolism) and In Vivo (Xenograft) Studies in T-47D Breast Cancer Models

Poirier, D., Roy, J., & Maltais, R. (2021) · Cancers · doi:10.3390/cancers13081841 · Cited by 20

Novel, potent and selective 17β-hydroxysteroid dehydrogenase type 2 inhibitors as potential therapeutics for osteoporosis with dual human and mouse activities

Perspicace, E., Cozzoli, L., Gargano, E. M., Hanke, N., Carotti, A., Hartmann, R. W., & Marchais‐Oberwinkler, S. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.06.036 · Cited by 19

Neurosteroids: A potential target for neuropsychiatric disorders

Wang, M., Hu, S.-W., Fu, X., Zhou, H., Yang, S., & Yang, C. (2024) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2024.106485 · Cited by 18

Design, chemical synthesis and biological evaluation of 3-spiromorpholinone/3-spirocarbamate androsterone derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 3

Djigoué, G. B., Kenmogne, L. C., Roy, J., Maltais, R., & Poirier, D. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.07.049 · Cited by 18

Metabolic stability optimization and metabolite identification of 2,5-thiophene amide 17β-hydroxysteroid dehydrogenase type 2 inhibitors

Gargano, E. M., Perspicace, E., Hanke, N., Carotti, A., Marchais‐Oberwinkler, S., & Hartmann, R. W. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.061 · Cited by 18

Treatment of estrogen-dependent diseases: Design, synthesis and profiling of a selective 17β-HSD1 inhibitor with sub-nanomolar IC 50 for a proof-of-principle study

Abdelsamie, A. S., van Koppen, C. J., Bey, E., Salah, M., Börger, C., Siebenbürger, L., Laschke, M. W., Menger, M. D., & Frotscher, M. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.11.004 · Cited by 18

Pharmacokinetic profile of PBRM in rodents, a first selective covalent inhibitor of 17β-HSD1 for breast cancer and endometriosis treatments

Maltais, R., Trottier, A., Roy, J., Ayan, D. P., Bertrand, N., & Poirier, D. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.12.007 · Cited by 18

Steroid Hormones and Other Lipid Molecules Involved in Human Reproduction

Strauss, J. F., & FitzGerald, G. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00004-4 · Cited by 21

The effect of environmental mycotoxins on selected ovarian tissue fragments of multiparous female wild boars at the beginning of astronomical winter

Zielonka, Ł., Gajęcka, M., Rozicka, A., Dąbrowski, M., Żmudzki, J., & Gajęcki, M. T. (2014) · Toxicon · doi:10.1016/j.toxicon.2014.06.021 · Cited by 18

Exploring the anti-breast cancer potential of flavonoid analogs

Thakor, V., Poddar, M., Dey, S. K., Manjula, S. N., Madhunapantula, S. V., Pawara, R. H., Patel, H., & Noolvi, M. N. (2016) · RSC Advances · doi:10.1039/c6ra14428d · Cited by 18

17β-HSD type 12-like is responsible for maturation-inducing hormone synthesis during oocyte maturation in masu salmon12

Ijiri, S., Shibata, Y., Takezawa, N., Kazeto, Y., Takatsuka, N., Kato, E., Hagihara, S., Ozaki, Y., Adachi, S., Yamauchi, K., et al. (2016) · Endocrinology · doi:10.1210/en.2016-1349 · Cited by 17

Integrated assessment of endocrine disrupting potential of four novel brominated flame retardants

Zhang, Q., Gu, S., Chang, Y., Cao, R., Xu, Y., Fu, L., & Wang, C. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113206 · Cited by 17

Ovarian Endocrinology

Takae, S., & Suzuki, N. (2017) · Springer eBooks · doi:10.1007/978-3-319-53454-1_1 · Cited by 17

Association of HSD17B13 rs72613567: TA allelic variant with liver disease: review and meta-analysis

Tang, S., Zhang, J., Mei, T., Zhang, W., Zheng, S.-J., & Yu, H. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-02067-y · Cited by 16

Hydrohysteroid Dehydrogenases – Biological Role and Clinical Importance – Review

Atanassova, N. N., & Koev, Y. (2012) · InTech eBooks · doi:10.5772/54149 · Cited by 16

A role for the dehydrogenase DHRS7 (SDR34C1) in prostate cancer

Seibert, J., Quagliata, L., Quintavalle, C., Hammond, T. G., Terracciano, L., & Odermatt, A. (2015) · Cancer Medicine · doi:10.1002/cam4.517 · Cited by 16

Impact of structural modifications at positions 13, 16 and 17 of 16β-(m-carbamoylbenzyl)-estradiol on 17β-hydroxysteroid dehydrogenase type 1 inhibition and estrogenic activity

Maltais, R., Trottier, A., Barbeau, X., Lagüe, P., Perreault, M., Thériault, J.-F., Lin, S., & Poirier, D. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.10.020 · Cited by 16

Comparative investigation of thein vitroinhibitory potencies of 13-epimeric estrones and D-secoestrones towards 17β-hydroxysteroid dehydrogenase type 1

Herman, B. E., Szabó, J., Bacsa, I., Woelfling, J., Schneider, G., Bálint, M., Hetényi, C., Mernyák, E., & Szécsi, M. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2016.1204610 · Cited by 16

Development of adverse outcome pathways relevant for the identification of substances having endocrine disruption properties Uterine adenocarcinoma as adverse outcome

(PPR), E. P. O. P. P. P. A. T. R., Hernández, A. F., Adriaanse, P., Aldrich, A., Berny, P. J., Čoja, T., Duquesne, S., Focks, A., Millet, M., Pelkonen, O., et al. (2023) · EFSA Journal · doi:10.2903/j.efsa.2023.7744 · Cited by 18

Design and validation of specific inhibitors of 17 -hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis

Day, J. M., Tutill, H. J., Purohit, A., & Reed, M. J. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0042 · Cited by 123

Advances in Development of Inhibitors of 17β-Hydroxysteroid Dehydrogenases

Poirier, D. (2009) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152009788680000 · Cited by 57

Inhibitors of 17β-Hydroxysteroid Dehydrogenases

Poirier, D. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033368222 · Cited by 177

Recent advances in the development of 17beta-hydroxysteroid dehydrogenase inhibitors

Poirier, D. (2024) · Steroids · doi:10.1016/j.steroids.2024.109529 · Cited by 12

Contribution to the development of inhibitors of 17β-hydroxysteroid dehydrogenase types 1 and 7: Key tools for studying and treating estrogen-dependent diseases

Poirier, D. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.12.007 · Cited by 44